Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
NCT06405295
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Breast Carcinoma
BRCA Mutation
Adjuvant Drug Therapy
Interventions
OTHER:
no intervention
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences